1 completed, 1 not yet recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
Follow R. Kiplin Guy: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| This is a Clinical Study to Assess Whether the Combination of SJ733 and Tafenoquine Will be a Safe and Rapidly Acting Anti-malarial for the Radical Cure of P. Vivax Malaria SJ733/TQ placebo, CQ/TQ Placebo, CQ/TQ - Malaria, Malaria Vivax | Phase 2 | Not yet recruiting | R. Kiplin Guy | 104 | 2026-12-01 | 2026-10-21 |
| Efficacy of SJ733 in Adults With Uncomplicated Plasmodium Falciparum or Vivax Malaria (+)-SJ000557733 (SJ733) - Malaria, Falciparum, Malaria, Vivax | Phase 2 | Completed | R. Kiplin Guy | 22 | 2021-04-14 | 2023-12-04 |
Malaria, Vivax (2) · Malaria (1) · Malaria, Falciparum (1)
SJ733 (2) · Chloroquine (1) · tafenoquine (1)
Peru (2)
Alejandro L Cuentas, MD, PhD (1) · Alejandro L Cuentas,, MD, PhD (1) · Rodney K Guy, PhD (1)